Computed tomography-derived quantitative imaging biomarkers enable the prediction of disease manifestations and survival in patients with systemic sclerosis
Malte Maria Sieren(Universitäres Kinderwunschzentrum Lübeck), Franz Wegner(University Hospital Schleswig-Holstein), Jörg Barkhausen(University Hospital Schleswig-Holstein), Gabriela Riemekasten(Universitäres Kinderwunschzentrum Lübeck), Lennart Berkel(University Hospital Schleswig-Holstein), Roman Kloeckner(University Hospital Schleswig-Holstein), Felix Nensa(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Hanna Graßhoff(University of Lübeck), René Hosch(Essen University Hospital)
Cited by 1
Related Papers
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement
|Lara D. Veeken|2008|287
Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study
|Radiation and Environmental Biophysics|2015|178
Explainable AI in medical imaging: An overview for clinical practitioners – Beyond saliency-based XAI approaches
|European Journal of Radiology|2023|170